Published:  02:01 PM, 13 October 2020

Johnson & Johnson pauses COVID-19 vaccine trial over patient illness

Johnson & Johnson pauses COVID-19 vaccine trial over patient illness

U.S. pharmaceutical company Johnson & Johnson said Monday it had paused its COVID-19 vaccine trial because one of its participants had become sick.

"We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement.

The patient's condition was being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as internal clinical and safety physicians, it said.


Leave Your Comments



Latest News


More From Health

Go to Home Page »

Site Index The Asian Age